Meyka Pro banner
Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (INBS) Stock Overview

Explore Intelligent Bio Solutions Inc.’s financial performance, market position, analyst ratings, and future outlook.

INBSNASDAQ
HealthcareMedical - Diagnostics & Research
$1.79
$0.02(1.10%)
U.S. Market opens in 12h 45m

Intelligent Bio Solutions Inc. (INBS)

Meyka AI Score

Z

Key Financials

Market Cap1.2M
P/E Ratio-0.14
EPS (TTM)$-8.49
ROE-1.74%
Fundamental Analysis

AI Price Forecasts

1 Month$1.59
3 Months$3.74
1 Year Target$0.00

INBS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Intelligent Bio Solutions Inc. (NASDAQ: INBS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Intelligent Bio Solutions Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of INBS on the NASDAQ shows an RSI of 43.13, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Intelligent Bio Solutions Inc.'s NASDAQ-traded stock include a P/E ratio of -0.14 and a market capitalization of 1.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of INBS on the NASDAQ.

Price Performance (NASDAQ: INBS)

1-Day Change
1.10%
5-Day Change
15.82%
1-Month Change
-19.74%
3-Month Change
-24.38%
6-Month Change
-71.04%
Year-to-Date (YTD) Change
-80.80%
1-Year Change
-87.80%
3-Year Change
-98.96%
5-Year Change
-99.98%
All-Time (Max) Change
-99.99%

Contact Information

646 828 8258
142 West 57th Street, New York City, NY, 10019

Company Facts

550 Employees
IPO DateDec 23, 2020
CountryUS
Actively Trading

Frequently Asked Questions